Here are relevant reports on : clinical-documentation-improvement-market
-
Europe Chromatography Accessories & Consumables Market by Product (Column, Autosampler, Tubing, Detector, Fraction Collector), Technology (HPLC, UPLC, LPLC GC), Enduser (Pharma-biopharma, F&B, CROS, Clinical Labs, Petrochem, ENV Labs) - Forecast to 2031
The Europe chromatography accessories and consumables market, valued at USD1.67 billion in 2025, stood at USD1.78 billion in 2026 and is projected to advance at a resilient CAGR of 7.2% from 2026 to 2031, culminating in a forecasted valuation of USD2.53 billion by the end of the period. The market for chromatographic systems is driven by regulatory needs for accurate environmental monitoring and chemical testing. In Europe, the pharmaceutical and biotechnology industries are expanding the market through the essential use of HPLC, UPLC, and GC consumables in drug discovery and quality control.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Clinical Chemistry Analyzers Market by Product [Analyzers (Fully Automated, PoC, Semi-automated), Reagents], Test Type [Lipid Profile, Liver, Basic Metabolic Panels], End User [Hospitals & Clinics, Research, Labs], Region - Global Forecast to 2030
The global clinical chemistry analyzers market, valued at US$15.23 billion in 2024, stood at US$15.92 billion in 2025 and is projected to advance at a resilient CAGR of 5.6% from 2025 to 2030, culminating in a forecasted valuation of US$20.86 billion by the end of the period. The growing adoption of point-of-care testing and laboratory automation is also supporting market expansion across healthcare settings.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
RTD Protein Beverages Market, By Source (Milk, whey, Casein, Egg, Soy, Rice), By Types (Weight Management Drinks, Clinical Drinks, Energy Drinks, Juice Drinks) - Trends & Forecast to 2018
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
3D Bioprinting Market by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM), Application (Research (Regenerative Medicine, 3D cell Culture), Clinical (Skin, Bone)) - Global Forecast to 2029
The global 3D bioprinting market, valued at US$1.2 billion in 2023, stood at US$1.3 billion in 2024 and is projected to advance at a resilient CAGR of 12.7% from 2024 to 2029, culminating in a forecasted valuation of US$2.4 billion by the end of the period. The market growth is fueled by the growing adoption of 3D bioprinting technology in the pharmaceutical and cosmetic industries, technological advancements in 3D bioprinting, and the rising demand for organ transplants.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Plant Growth Chambers Market by Equipment Type (Reach-in, Walk-in), Application (Short Plants, Tall Plants), End Use (Clinical, Academic), Function (Plant Growth, Environmental Optimization), and Region - Global Forecast to 2022
The plant growth chambers market is projected to reach USD 485.6 Million by 2022 from USD 398.2 Million in 2017, growing at a CAGR of 4.0% during the forecast period. Increase in demand for food and technological advancements in biological engineering are some of the major factors that are expected to drive the demand for plant growth chambers. This report includes a study of various plant growth chambers, along with the product portfolios of leading companies. It includes the profiles of leading companies such as Thermo Fisher (US), Conviron (Canada), CARON (US), Percival Scientific (US), and BINDER (Germany).
- Published: January 2018
- Price: $ 4950
- TOC Available:
-
IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) - Global Forecast to 2028
The global IVD contract manufacturing market, valued at US$14.2 billion in 2022, stood at US$15.4 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth in this market can primarily be attributed to the growing need for less costly and better equipment's, increased need for IVD OEMs to establish themselves in the high potential market and emerge as a budding player in other allied markets, reduced risk of development failure, and reduction in cross contamination of IVD consumables at the CMO facility, and emergence of small scaled outsourcing facilities in emerging nations.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & Development, Clinical Diagnostics), End User & Region - Global Forecast to 2029
The global gene expression analysis market, valued at US$3.9 billion in 2023, stood at US$4.2 billion in 2024 and is projected to advance at a resilient CAGR of 8.1% from 2024 to 2029, culminating in a forecasted valuation of US$6.2 billion by the end of the period. Growth in this market is primarily driven by the increasing investments by pharmaceutical & biotechnology companies for genome based studies.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Contract Manufacturing Market by Service (Manufacturing, Fill-Finish), Type (Drug Substance, Drug Product), Scale (Clinical), Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines) - Global Forecast to 2030
The global biopharmaceutical contract manufacturing market, valued at US$20.51 billion in 2024, stood at US$22.40 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of US$34.15 billion by the end of the period. The growth is primarily driven by the rising demand for outsourcing services and an increasing need for biologics and biosimilars. However, challenges related to intellectual property rights are anticipated to pose barriers to market growth.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Contract Research Organization (CRO) Services Market by Type (Early Phase, Clinical, Lab, Consulting), Therapeutic Area (Cancer (Breast, Lung), Infectious, Neurology, Vaccines), Modality (Small Molecules, Biologics, Biosimilars) - Global Forecast to 2030
The global contract research organization (CRO) services market, valued at US$79.10 billion in 2024, stood at US$84.61 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2030, culminating in a forecasted valuation of US$125.95 billion by the end of the period. Factors such as the increasing complexity & the growing volume of trials; the rising focus on patient-centric clinical trials such as Decentralized Clinical trials (DCTs); and the flexibility of services offered by CROs are supporting the growth of this market.
- Published: September 2025
- Price: $ 7150
- TOC Available:
-
US Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer, ASC) - Forecast to 2030
The US Telehealth & Telemedicine Market, valued at US$46.10 billion in 2024, stood at US$51.40 billion in 2025 and is projected to advance at a resilient CAGR of 10.2% from 2025 to 2030, culminating in a forecasted valuation of US$83.63 billion by the end of the period. In the US, permanent CMS reimbursement expansions and state-level payment parity laws are driving telehealth growth by securing fair, ongoing reimbursement comparable to in-person care.
- Published: April 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
